Klotho Competitors

Stocks . USA . 
Stock . Klotho Neurosciences
KLTO Stock   0.28  0.01  3.45%   
Klotho Neurosciences competes with Cadrenal Therapeutics, Rallybio Corp, Exicure, Minerva Neurosciences, and IBio Common; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Klotho Neurosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Klotho Neurosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Klotho Neurosciences Correlation with its peers.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.

Klotho Neurosciences vs Neuraxis Correlation

Pay attention - limited upside

The correlation between Klotho Neurosciences and NRXS is -0.88 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Klotho Neurosciences and NRXS in the same portfolio, assuming nothing else is changed.

Moving against Klotho Stock

  0.78BA BoeingPairCorr
  0.72ABEV Ambev SA ADR Aggressive PushPairCorr
  0.68AA Alcoa CorpPairCorr
  0.55WMT Walmart Common StockPairCorr
  0.54XOM Exxon Mobil Corp Earnings Call TomorrowPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.286.33
Details
Intrinsic
Valuation
LowRealHigh
0.010.276.32
Details
Naive
Forecast
LowNextHigh
0.010.276.32
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.280.320.36
Details

Klotho Neurosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Klotho Neurosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Klotho and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Klotho Neurosciences does not affect the price movement of the other competitor.

High positive correlations

TAOX
+ 0.87
CVKD
NRXS
+ 0.75
IBIO
IBIO
+ 0.64
XCUR
TAOX
+ 0.61
NRSN
XCUR
+ 0.57
RLYB
IBIO
+ 0.54
RLYB
  

High negative correlations

NRXS
- 0.77
CVKD
NRXS
- 0.74
TAOX
TAOX
- 0.62
XCUR
XCUR
- 0.59
CVKD
TAOX
- 0.58
IBIO
NRSN
- 0.57
RLYB

Risk-Adjusted Indicators

There is a big difference between Klotho Stock performing well and Klotho Neurosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Klotho Neurosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CVKD  4.78 (0.81) 0.00 (0.41) 0.00 
 0.00 
 8.11 
(8.29)
 58.15 
RLYB  2.93 (0.10) 0.00 (0.01) 0.00 
 0.00 
 6.94 
(5.71)
 15.72 
XCUR  6.12  0.52  0.04 (0.32) 8.95 
(6.68)
 21.22 
(11.88)
 63.80 
NERV  3.74  0.09  0.01  0.29  5.35 
(3.58)
 6.88 
(9.05)
 25.06 
IBIO  7.53  0.96  0.12  2.56  6.93 
(9.82)
 23.08 
(11.24)
 59.00 
NRSN  4.54 (0.09) 0.00  0.88  0.00 
 0.00 
 12.82 
(7.48)
 34.62 
SONN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TAOX  5.73 (0.96) 0.00 (0.23) 0.00 
 0.00 
 11.74 
(10.43)
 34.68 
MTVA  7.76 (1.76) 0.00  1.66  0.00 
 0.00 
 11.60 
(20.10)
 79.95 
NRXS  3.73  0.95  0.22  0.79  3.69 
(4.50)
 7.88 
(5.70)
 38.80 

Klotho Neurosciences Competitive Analysis

The better you understand Klotho Neurosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Klotho Neurosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Klotho Neurosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KLTO CVKD RLYB XCUR NERV IBIO NRSN SONN TAOX MTVA
 3.45 
 0.28 
Klotho
 2.61 
 7.46 
Cadrenal
 4.69 
 0.67 
Rallybio
 1.67 
 4.26 
Exicure
 0.72 
 4.20 
Minerva
 3.59 
 2.15 
IBio
 2.15 
 0.95 
Neurosense
 60.13 
 1.26 
Sonnet
 9.41 
 4.62 
TAO
 0.85 
 2.36 
MetaVia
Market Volatility
(90 Days Market Risk)
Out of control
Relatively risky
Abnormally volatile
Dangerous
Risky
Abnormally volatile
Abnormally volatile
Very steady
Very risky
Extremely Dangerous
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Soft
Weak
Fair
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Risky
Low
Risky
Risky
Strong
High
Hazard
Risky
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
21.2
1.26
20.41
1.48
15.09
1.1
N/A
N/A
Net Asset
2.46 M
10.12 M
68.11 M
15.06 M
37.14 M
23.18 M
4.58 M
14.88 M
17.73 M
16.26 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(5.79 M)
(10.65 M)
(60.37 M)
(8.85 M)
6.02 M
(17.04 M)
(9.88 M)
(15.84 M)
(6.81 M)
(28.79 M)
Current Valuation
24.07 M
13.45 M
(32.08 M)
24.29 M
168.6 M
4.98 M
23.72 M
8.35 M
11.07 M
(6.44 M)
Price To Book
2.3
6.51
0.43
4.09
2.68
0.91
12.82
2.07
1.43
1.23
Operating Margin
N/A
N/A
-32.67
N/A
N/A
-59.51
N/A
-14.06
-589.6
N/A
Retained Earnings
(10.56 M)
(25.72 M)
(293.02 M)
(199.26 M)
(395.38 M)
(332.22 M)
(36.66 M)
(133.69 M)
(47.17 M)
(135.86 M)
Current Asset
N/A
N/A
N/A
N/A
33.48 M
23.91 M
N/A
N/A
N/A
N/A
Beta
2.48
1.21
-1.05
4.07
-0.42
1.15
1.57
1.47
2.04
0.27
Number Of Employees
3
4
15
7
8
20
17
13
4
9
Shares Outstanding
72.54 M
2.34 M
42.24 M
6.37 M
6.99 M
22.49 M
29.55 M
6.83 M
3.49 M
3.32 M
Cash Flow From Operations
(2.95 M)
(7.36 M)
(49.28 M)
(2.91 M)
(19.55 M)
(15.3 M)
(10.13 M)
(12.83 M)
(4.88 M)
(24.71 M)
Total Debt
271.75 K
2.68 M
154 K
5.93 M
60 M
3.51 M
73 K
46.57 K
10.96 M
136 K
Return On Equity
-1.98
-4.68
-0.21
-2.18
-6.75
-0.55
-24.78
-7.15
-1.55
-1.68
Return On Asset
-0.72
-2.09
-0.28
-0.45
-0.26
-0.29
-3.04
-2.24
-0.18
-0.58
Number Of Shares Shorted
391.81 K
58.36 K
116.61 K
88.15 K
321.38 K
3.89 M
574.18 K
2.15 M
319.99 K
163.19 K
Book Value Per Share
0.14
1.33
1.5
1.09
-4.94
2.77
-0.021
-0.91
6.89
2.88
Current Liabilities
N/A
N/A
N/A
N/A
5.32 M
2.29 M
N/A
N/A
N/A
N/A
Total Asset
2.46 M
10.12 M
68.11 M
15.06 M
37.14 M
23.18 M
4.58 M
14.88 M
17.73 M
16.26 M
Short Ratio
0.61
0.75
0.56
1.25
0.05
1.23
1.15
3.27
3.27
1.28
Target Price
N/A
35.67
1.0
2.0
4.0
4.72
11.5
20.0
N/A
91.0
Debt To Equity
N/A
N/A
0.004
6.53
0.001
0.44
0.019
0.36
N/A
N/A
Shares Owned By Institutions
2.56
8.3
67.0
5.98
28.26
57.76
1.71
9.95
1.7
4.71
Market Capitalization
22.49 M
17.91 M
27.04 M
26.71 M
26.92 M
50.15 M
27.11 M
8.6 M
33.48 M
7.76 M
Price To Earning
N/A
N/A
N/A
N/A
69.58
-2.18
N/A
N/A
N/A
N/A
Price To Sales
N/A
N/A
40.12
74.42
1.87
100.29
N/A
8.6
8449.42
N/A
Net Income
(6.15 M)
(10.65 M)
(57.77 M)
(9.7 M)
1.44 M
(18.38 M)
(10.21 M)
(16.01 M)
(12.77 M)
(27.59 M)
Earnings Per Share
-0.3
-8.72
-0.32
-3.72
-1.85
-1.4
-0.36
-6.82
-21.31
-10.45
Shares Owned By Insiders
10.53
22.3
4.1
35.38
22.25
3.35
25.55
4.24
1.66
55.5
Revenue
N/A
N/A
636 K
500 K
N/A
400 K
N/A
1000 K
N/A
N/A
Working Capital
(1.09 M)
7.43 M
61.6 M
10.6 M
19.43 M
3.62 M
2.41 M
(1.09 M)
16.71 M
7.8 M
Cash And Equivalents
N/A
N/A
147.37 M
22.2 M
40.22 M
33.52 M
10.37 M
5.22 M
N/A
N/A
Cash Per Share
N/A
N/A
4.59
4.47
7.53
3.72
0.89
1.21
N/A
N/A
Gross Profit
N/A
N/A
(38.36 M)
(2.63 M)
(5.57 M)
500 K
N/A
(767.53 K)
3.96 K
N/A
Day Typical Price
0.28
7.47
0.67
4.18
4.18
2.15
0.93
1.92
4.8
2.36
Accumulation Distribution
50694.6
2664.14
20350.99
2557.81
3036.76
28213.86
8107.33
0.61
25100.4
2772.58
Market Facilitation Index
N/A
0.0
N/A
0.0
0.0
N/A
0.0
1.97
0.0
0.0
Daily Balance Of Power
(0.33)
(0.37)
0.375
0.25
0.125
(0.73)
0.2857
(0.96)
(0.62)
0.2857
Period Momentum Indicator
(0.01)
(0.20)
0.03
0.07
0.03
(0.08)
0.02
(1.90)
(0.48)
0.02
Rate Of Daily Change
0.97
0.97
1.05
1.02
1.01
0.96
1.02
0.4
0.91
1.01
Day Median Price
0.29
7.47
0.67
4.14
4.17
2.16
0.92
2.25
4.89
2.37
Price Action Indicator
(0.01)
(0.11)
0.015
0.15
0.045
(0.04)
0.045
(1.93)
(0.51)
0.005
Relative Strength Index
37.57
41.22
47.42
41.37
50.26
51.67
49.38
38.22
41.98
31.39
Coefficient Of Variation
(699.93)
(1,028)
(114,393)
2251.82
4039.45
1067.74
(7,442)
N/A
(961.01)
(624.54)
Mean Deviation
4.68
4.78
2.93
6.12
3.74
7.53
4.54
N/A
5.73
7.76
Jensen Alpha
(1.04)
(0.81)
(0.1)
0.52
0.0932
0.9625
(0.09)
N/A
(0.96)
(1.76)
Total Risk Alpha
(1.30)
(1.24)
(0.28)
(0.28)
(0.24)
0.2335
(0.53)
N/A
(1.31)
(2.62)
Sortino Ratio
N/A
N/A
N/A
0.042
0.0111
0.1235
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
89.26
31.03
56.85
N/A
N/A
N/A
N/A
Standard Deviation
6.05
7.3
3.76
10.31
4.97
10.59
6.22
N/A
7.42
11.31
Kurtosis
0.7052
7.44
0.1675
4.12
0.7419
3.15
1.45
N/A
0.4624
4.29
Potential Upside
10.34
8.11
6.94
21.22
6.88
23.08
12.82
N/A
11.74
11.6
Treynor Ratio
(0.26)
(0.41)
(0.01)
(0.32)
0.2907
2.56
0.8837
N/A
(0.23)
1.66
Maximum Drawdown
28.13
58.15
15.72
63.8
25.06
59.0
34.62
N/A
34.68
79.95
Variance
36.57
53.27
14.11
106.32
24.75
112.22
38.69
N/A
55.09
127.85
Market Risk Adjusted Performance
(0.25)
(0.40)
0.0018
(0.31)
0.3007
2.57
0.8937
N/A
(0.22)
1.67
Risk Adjusted Performance
(0.09)
(0.06)
0.0074
0.0415
0.0265
0.0773
(0.0009)
N/A
(0.07)
(0.11)
Skewness
0.7941
(0.54)
0.6033
0.734
(0.29)
1.43
0.7543
N/A
0.3059
(0.04)
Semi Deviation
N/A
N/A
N/A
8.95
5.35
6.93
N/A
N/A
N/A
N/A
Information Ratio
(0.15)
(0.11)
(0.02)
0.0385
0.0124
0.0879
(0.02)
N/A
(0.11)
(0.17)
Value At Risk
(8.57)
(8.29)
(5.71)
(11.88)
(9.05)
(11.24)
(7.48)
N/A
(10.43)
(20.10)
Expected Short fall
N/A
N/A
N/A
(6.68)
(3.58)
(9.82)
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
9.45
5.57
7.54
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
80.15
28.6
47.97
N/A
N/A
N/A
N/A

Klotho Neurosciences Competition Performance Charts

Five steps to successful analysis of Klotho Neurosciences Competition

Klotho Neurosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Klotho Neurosciences in relation to its competition. Klotho Neurosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Klotho Neurosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Klotho Neurosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Klotho Neurosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Klotho Neurosciences position

In addition to having Klotho Neurosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Companies manufacturing textile accessories and apparel products. The Apparel theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Klotho Neurosciences is a strong investment it is important to analyze Klotho Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Klotho Neurosciences' future performance. For an informed investment choice regarding Klotho Stock, refer to the following important reports:
How To Invest In Klotho
Details
Is Klotho Stock a good investment?
Details
What is Klotho Neurosciences' Net Worth?
Details
Top Sectors
View
Check out Klotho Neurosciences Correlation with its peers.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Stock sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY